Scientific Publications

Search by Keyword(s)
Found 4 results

Filters: Author is Tchaicha, JH  [Clear All Filters]

Search Results

  • Showing 1-4 of 4 Results
2014
Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a pan-FGFR inhibitor in a mouse model of NSCLC.Wong, KK, Tchaicha JH, Akbay EA, Altabef A., Mikse OR, Kikuchi E., Rhee K., Liao RG, Bronson RT, Sholl LM, Meyerson M., and Hammerman PS Cancer research, 2014/07/17, (2014) Read More / View Supplemental Materials
Abstract
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression.Xu, C., Fillmore CM, Koyama S., Wu H., Zhao Y., Chen Z., Herter-Sprie GS, Akbay EA, Tchaicha JH, Altabef A., Reibel JB, Walton Z., Ji H., Watanabe H., Jänne PA, Castrillon DH, Rustgi AK, Bass AJ, Freeman GJ, Padera RF, et al. Cancer cell, 2014/05/12, Volume 25, Issue 5, p.590-604, (2014) Read More / View Supplemental Materials
Abstract
2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.Akbay, EA, Koyama S., Carretero J., Altabef A., Tchaicha JH, Christensen CL, Mikse OR, Cherniack AD, Beauchamp EM, Pugh TJ, Wilkerson MD, Fecci PE, Butaney M., Reibel JB, Soucheray M., Cohoon TJ, Janne PA, Meyerson M., Hayes DN, Shapiro GI, et al. Cancer discovery, 2013/09/27, (2013) Read More / View Supplemental Materials
Abstract
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Liao, RG, Jung J., Tchaicha JH, Wilkerson MD, Sivachenko A., Beauchamp EM, Pugh TJ, Pedamallu CS, Hayes DN, Gray NS, Getz G., Wong KK, Meyerson M., and Hammerman PS Cancer research, 2013/06/20, (2013) Read More / View Supplemental Materials
Abstract
  • Showing 1-4 of 4 Results